These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20709548)

  • 1. Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions.
    Joce C; Stahl JA; Shridhar M; Hutchinson MR; Watkins LR; Fedichev PO; Yin H
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5411-3. PubMed ID: 20709548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zhankuic acid A isolated from Taiwanofungus camphoratus is a novel selective TLR4/MD-2 antagonist with anti-inflammatory properties.
    Chen YF; Shiau AL; Wang SH; Yang JS; Chang SJ; Wu CL; Wu TS
    J Immunol; 2014 Mar; 192(6):2778-86. PubMed ID: 24532584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An MD2 hot-spot-mimicking peptide that suppresses TLR4-mediated inflammatory response in vitro and in vivo.
    Liu L; Ghosh N; Slivka PF; Fiorini Z; Hutchinson MR; Watkins LR; Yin H
    Chembiochem; 2011 Aug; 12(12):1827-31. PubMed ID: 21678541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of Toll-like receptor 4 by endotoxin.
    Teghanemt A; Re F; Prohinar P; Widstrom R; Gioannini TL; Weiss JP
    J Biol Chem; 2008 Jan; 283(3):1257-1266. PubMed ID: 17977838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study.
    Qiao S; Zhang H; Sun F; Jiang Z
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4b-binding protein negatively regulates TLR4/MD-2 response but not TLR3 response.
    Morita N; Yamazaki T; Murakami Y; Fukui R; Yamai I; Ichimonji I; Nakashima A; Nagaoka F; Takagi H; Miyake K; Akashi-Takamura S
    FEBS Lett; 2017 Jun; 591(12):1732-1741. PubMed ID: 28542817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational design principles for bioactive dendrimer based constructs as antagonists of the TLR4-MD-2-LPS complex.
    Barata T; Teo I; Lalwani S; Simanek E; Zloh M; Shaunak S
    Biomaterials; 2011 Nov; 32(33):8702-11. PubMed ID: 21864902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.
    Tsukamoto H; Ihara H; Ito R; Ukai I; Suzuki N; Kimoto M; Tomioka Y; Ikeda Y
    Biochem Biophys Res Commun; 2013 Oct; 440(1):31-6. PubMed ID: 24021278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
    Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
    Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico.
    Mobarak E; Håversen L; Manna M; Rutberg M; Levin M; Perkins R; Rog T; Vattulainen I; Borén J
    Sci Rep; 2018 Sep; 8(1):13600. PubMed ID: 30206272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway
    Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin.
    Resman N; Vasl J; Oblak A; Pristovsek P; Gioannini TL; Weiss JP; Jerala R
    J Biol Chem; 2009 May; 284(22):15052-60. PubMed ID: 19321453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies.
    Omotuyi O; Matsunaga H; Ueda H
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S223-9. PubMed ID: 25604147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1:TLR4:MD-2 axes.
    Sun S; He M; Wang Y; Yang H; Al-Abed Y
    PLoS One; 2018; 13(2):e0193028. PubMed ID: 29447234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2.
    Visintin A; Halmen KA; Latz E; Monks BG; Golenbock DT
    J Immunol; 2005 Nov; 175(10):6465-72. PubMed ID: 16272300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Approaches to Toll-Like Receptor 4 Modulation.
    Billod JM; Lacetera A; Guzmán-Caldentey J; Martín-Santamaría S
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.